Press release
Cancer/Tumor Profiling Market Insights into Precision Medicine | Business Report 2025-2034
CancerTumour Profiling Market 2025
Cancer/tumour profiling market size was valued at USD 8.37 billion in 2020 and is projected to reach USD 21.41 billion by 2034, growing at a CAGR of 11% from 2022 to 2034.
Cancer/Tumour Profiling ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐, ๐๐๐จ๐ฉ๐, ๐๐ง๐ ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐5-๐๐๐๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ก๐๐ฌ ๐๐๐๐ง ๐๐๐๐๐ ๐ญ๐จ ๐๐ฑ๐๐๐ญ๐ข๐ญ๐ฎ๐๐ ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐๐ง๐๐ฒ'๐ฌ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฅ๐๐๐ญ๐ข๐จ๐ง. The Global Cancer/Tumour Profiling Market Study, a comprehensive analysis of the market that spans more than 150+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2034. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
๐๐๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐ฌ๐ ๐๐จ๐ซ๐ฉ๐จ๐ซ๐๐ญ๐ ๐๐ฆ๐๐ข๐ฅ ๐๐ ๐๐จ๐ซ ๐ ๐๐ฎ๐ข๐๐ค ๐๐๐ฌ๐ฉ๐จ๐ง๐ฌ๐):
https://exactitudeconsultancy.com/reports/11006/cancer-tumour-profiling-market/#request-a-sample
[Note: Our free sample report includes a concise introduction the research report, Table of Contents, a list of tables and figures, an overview of the competitive landscape, geographic segmentation, and insights in innovations and future developments based on the research methodology.]
๐๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ฌ ๐๐ฅ๐ฌ๐จ ๐๐ฏ๐๐ข๐ฅ๐๐๐ฅ๐ ๐ข๐ง ๐ญ๐ก๐ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ ๐ฅ๐๐ง๐ ๐ฎ๐๐ ๐๐ฌ: Japanese (ใใ/่ ซ็ใใญใใกใคใชใณใฐ), Korea (์/์ข ์ ํ๋กํ์ผ๋ง), china (็็/่ฟ็คๅๆ), French (Profilage du cancer/de la tumeur), German (Krebs-/Tumorprofilierung), and Italy (Profilazione del cancro/tumore), etc.
๐๐ก๐๐ญ ๐ข๐ฌ ๐๐๐ฐ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐๐๐5?
Comprehensive industry insights and market trends
In-depth analysis of key company players and competitive dynamics
Tailored reports and expert analyst support upon request
Recent market advancements and future growth potential
Custom regional or country-specific reports as needed
Strategic recommendations for market entry and expansion
Insights in emerging technologies and their market impact
Buy Full Report: https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=11006
Cancer/Tumor Profiling Market Dynamics
Drivers:
Increasing prevalence of cancer worldwide and rising demand for personalized medicine.
Advancements in genomic and proteomic technologies for cancer profiling.
Growing investment in cancer research and diagnostic technologies.
Restraints:
High costs associated with profiling technologies and lack of accessibility in developing regions.
Concerns over data privacy and ethical issues.
Opportunities:
Expansion of liquid biopsy technologies for non-invasive tumor profiling.
Integration of artificial intelligence and machine learning for predictive diagnostics.
Challenges:
Standardization of profiling techniques and ensuring data accuracy.
Market Competition:
The report evaluates each company based on factors such as product and application portfolios, market share, growth potential, future plans, and recent developments. Readers will gain comprehensive insights in the competitive landscape. Notably, the report highlights the strategies top players are leveraging sustain their dominance in the Global Cancer/Tumour Profiling arket. It also explores how market competition is expected to evolve in the coming years and how companies are positioning themselves stay ahead of the curve.
Top Companies Include:
Qiagen N.V., Illumina Inc., Neogenomics Inc., HTG Molecular Diagnostics, Inc., Genomic Health, Helomics Corporation, Caris Life Sciences, Nanostring Technologies, Oxford Gene Technology, Ribomed Biotechnologies Inc. and other.
โ ๐๐ซ๐จ๐ฐ๐ฌ๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ญ๐ก ๐๐๐ & ๐๐ข๐ฌ๐ญ ๐๐ ๐ ๐ข๐ ๐ฎ๐ซ๐:
https://exactitudeconsultancy.com/reports/11006/cancer-tumour-profiling-market
The Global Cancer/Tumour Profiling Market segments and Market Data Break Down are illuminated below:
Cancer/Tumour Profiling Market by Technology
Sequencing Technique
Next-Generation Sequencing (NGS)
In Situ Hybridization
Immunohistochemistry
Cancer/Tumour Profiling Market by Technique
Genomics
Metabolomics
Proteomics
Epigenetic
Cancer/Tumour Profiling Market by Application
Personalized Cancer Medicine
Oncological Diagnostics
Research Applications
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐จ๐ฏ๐๐ซ๐๐ ๐:
Region-wise segmentation of the global Cancer/Tumour Profiling market highlights the division of the market's regional scope. Among these regions, one is expected to secure the largest market share during the forecast period.
North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)
The report answers important questions that companies may have when operating in the Global Cancer/Tumour Profiling Market. Some of the questions are given below:
What is the current CAGR of the Global Cancer/Tumour Profiling Market?
Which product is expected to show the highest market growth?
Which application is projected to gain a lion's share of the Global Cancer/Tumour Profiling Market?
Which region is foretold to create the most number of opportunities in the Global Cancer/Tumour Profiling Market?
Will there be any changes in market competition during the forecast period?
Which are the top players currently operating in the global market?
How will the market situation change in the coming years?
What are the common business tactics adopted by players?
What is the growth outlook of the Global Cancer/Tumour Profiling Market?
๐๐ฎ๐ซ ๐ญ๐๐๐ฆ ๐ข๐ฌ ๐๐ฏ๐๐ข๐ฅ๐๐๐ฅ๐ ๐๐/๐ ๐ญ๐จ ๐๐ฌ๐ฌ๐ข๐ฌ๐ญ ๐๐ง๐ ๐ฌ๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ ๐จ๐ฎ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐๐ซ๐ฌ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐ซ๐๐ฅ๐ข๐๐๐ฅ๐ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก.
Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus twin them sufficient time and space for market competition.
- country-level analysis for the 5 countries of your choice.
- competitive analysis of 5 key market players.
- 40 free analyst hours to cover any other data point.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ญ๐ก๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐ซ๐๐ง๐๐ข๐ง๐ "๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐ซ๐ญ๐ข๐๐ฅ๐":
https://www.globalfinanceobserver.com/article/746120655-water-quality-instruments-market-is-exhibiting-a-cagr-of-7-10-during-the-forecast-period-exactitude-consultancy
https://www.latinamericainvestordaily.com/article/725162569-modular-substation-market-is-expected-to-reach-above-usd-33-86-billion-by-2034-exactitude-consultancy
http://www.telecomstoday.com/article/725959537-anisotropic-conductive-films-market-is-anticipated-to-grow-from-usd-2-94-billion-in-2024-to-usd-4-82-billion-by-2034-exactitude-consultancy
https://smb.alexcityoutlook.com/article/Fractional-Flow-Reserve-Market-growing-at-a-CAGR-of-1556percent-during-the-forecast-period-2025-2034-Exactitude-Consultancy?storyId=66952b0d3209286a26b7e884
https://www.syriabusinessjournal.com/article/729781737-chemical-mechanical-planarization-cmp-slurry-market-is-anticipated-to-grow-from-usd-2-50-billion-in-2025-to-usd-4-28-billion-by-2034-exactitude
https://pr.wis.community/article/Micro-and-Mini-LED-Display-Market-is-expected-to-be-valued-at-USD-1332-billion-by-2034-or-Exactitude-Consultancy?storyId=66a3666a709b0518e43ec199
https://investing.einnews.com/pr_news/731583310/multirotor-drones-market-is-expected-to-be-valued-at-usd-10-15-billion-by-2029-exactitude-consultancy
https://smb.americustimesrecorder.com/article/PET-Packaging-Market-is-expected-to-be-valued-at-USD-1934-billion-by-2034-or-Exactitude-Consultancy?storyId=66ace032709b0518e44f6f96
https://pr.greenvillebusinessmag.com/article/Battery-Materials-Market-is-expected-to-be-valued-at-USD-6212-billion-by-2034-or-Exactitude-Consultancy?storyId=66b60ca4ff399ea85e50a8ca
https://pr.rswliving.com/article/Global-Medical-Plastics-Market-to-Grow-from-USD-4487-Billion-in-2024-to-USD-7893-Billion-by-2031-with-a-CAGR-of-69percentor-Exactitude-Consultancy?storyId=66c5ecb3de91e57068231df8
https://www.micronesiabusinessdaily.com/article/742893480-advanced-process-control-market-projected-to-grow-from-usd-2-44-billion-in-2025-to-usd-4-89-billion-by-2029-at-a-cagr-of-8-14-exactitude
๐๐ข๐ฌ๐ข๐ญ ๐๐จ๐ซ๐ ๐๐ข๐ญ๐๐ฌ:
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Exactitude Consultancy is a market research & consulting services firm, which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
๐๐๐๐ข๐ ๐๐จ๐ง๐ญ๐๐๐ญ:
Exactitude Consultancy
PHONE NUMBER:ย +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer/Tumor Profiling Market Insights into Precision Medicine | Business Report 2025-2034 here
News-ID: 3847740 • Views: โฆ
More Releases from Exactitude Consultancy
Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 b โฆ
Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and blood. Despite advances in frontline therapies, relapse is common, and many patients develop refractory disease, leaving limited treatment options and poor survival outcomes. Relapsed/refractory AML (R/R AML) remains a major unmet clinical need.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71571
In recent years, however, theโฆ
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around 3% of all childhood cancers but is the most common intraocular malignancy in children. With improved awareness, early screening, and advances in treatment, survival rates in developed nations exceed 90%. However, challenges remain in low- and middle-income countries where delayed diagnosis and limited access toโฆ
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Lymphoma, a group of blood cancers affecting the lymphatic system, is broadly classified into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). While survival outcomes have improved significantly with chemotherapy, radiotherapy, targeted agents, and immunotherapies, many patients experience severe toxicities as side effects of treatment. These toxicities - ranging from cytokine release syndrome (CRS) and neurotoxicity in CAR-T therapy to myelosuppression, infections, and organ toxicities from chemotherapy and immunomodulators - canโฆ
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft tissue neoplasms are abnormal growths arising from connective tissues, including muscles, fat, nerves, tendons, and blood vessels. While some are benign, malignant forms such as soft tissue sarcomas (STS) pose serious clinical challenges due to their aggressive nature, rarity, and diverse histological subtypes. Representing about 1% of all adult cancers, these neoplasms require a wide spectrum of treatments ranging from surgery and radiotherapy to chemotherapy and novel targeted therapies.
Downloadโฆ
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by โฆ
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingโฆ
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio โฆ
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boostโฆ
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne โฆ
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of theโฆ
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve โฆ
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:โฆ
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance โฆ
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchโฆ
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung โฆ
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. Forโฆ
